Alum of Shane Victorino Nicetown Club. Rob has served as a Boys & Girls Clubs of Philadelphia board member, is currently a member of the Jeremiah Millbank Society, and is the Strategic Leader of our Bold Change for Kids cabinet. Rob began attending our Nicetown Wayne Avenue Club at the age of six and continued attending through the 12th grade when he was named Pennsylvania’s 1979 Youth of the Year. Rob graduated from Lafayette College in 1983 and from Cornell Law School in 1986. Before founding Ross Feller Casey along with Joel Feller and Matt Casey, Ross was a partner in three other Philadelphia law firms: Cohen, Shapiro, Polisher, Shiekman and Cohen; Fox Rothschild; and Kline & Specter.
Rob’s generosity defines both his personal and professional life. As a personal injury attorney, Rob helps rebuild the lives of those who have been seriously injured. His 30-year career has resulted in countless victories for his clients. Both through his work and his role with Boys & Girls Clubs of Philadelphia, Rob has positively impacted the lives of thousands of children. This past year, we were proud pay tribute to Rob as our Club Champion at the 2018 Philly Showcase of Wine & Cheese.
Michael Cola joined Aevi Genomic Medicine as President and CEO in September 2013. Prior to joining Aevi Genomic Medicine, Mr. Cola served as President of Specialty Pharmaceuticals at Shire plc, a global specialty pharmaceutical company, from 2007 until April 2012. He joined Shire in 2005 as EVP of Global Therapeutic Business Units and Portfolio Management. Prior to joining Shire, he was with Safeguard Scientifics, Inc., a growth capital provider to life sciences and technology companies, where he served as President of the Life Sciences Group. While at Safeguard, Mr. Cola served as Chairman and CEO of Clarient, Inc., a cancer diagnostics company subsequently acquired by GE Healthcare, and as Chairman of Laureate Pharma, Inc., a full-service contract manufacturing organization serving research-based biologics companies. Prior to Safeguard Scientifics, Mr. Cola held senior positions in product development and commercialization at AstraMerck, a top 20 U.S. pharmaceutical company, and at AstraZeneca, a global biopharmaceutical company.
Mr. Cola received a B.A. in biology and physics from Ursinus College and an M.S. in biomedical science from Drexel University. He serves on the Board of Directors of Vanda Pharmaceuticals Inc., Sage Therapeutics, and currently serves as Chairman of the Board of Governors of the Boys & Girls Clubs of Philadelphia. Mr. Cola also served on the Life Sciences Pennsylvania Board (formerly named Pennsylvania Bio) from 2009-2015.